EXTRA-PHARMA
ActiveSummary
EXTRA-PHARMA has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €559k and a net result of €98k. Equity is growing by ~3.4% per year across the filed fiscal years. Its solvency ranks better than 28% of 10407 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability60▲+7
Solvency43▲+4
Growth32▼-26
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 1.98 against 1.63 in 2024; short-term debt: 21.9% and cash: 5.2% of total assets), but 81.8% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.2%
Return on assets
3.2%
Age of the figures
18 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 29-09-2025, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 d early
2024
2 d early
2023
on the day
2022
3 d early
2021
15 d late
2020
17 d late
2019
7 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close25-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€559k▲ 17.2%
2024 · €477k
2019: €2.65M
2020: €2.85M▲ +7.7% vs 2019
2021: €2.95M▲ +3.4% vs 2020
2022: €3.18M▲ +8.0% vs 2021
2023: €3.34M▲ +4.9% vs 2022highest in 7 years
2024: €477k▼ -85.7% vs 2023lowest in 7 years
2025: €559k▲ +17.2% vs 2024
2019 → 2025
Total assets
€3.06M▼ 10.7%
2024 · €3.43M
2019: €3.46M
2020: €3.60M▲ +4.0% vs 2019
2021: €4.38M▲ +21.7% vs 2020
2022: €5.04M▲ +15.0% vs 2021
2023: €6.24M▲ +24.0% vs 2022highest in 7 years
2024: €3.43M▼ -45.0% vs 2023
2025: €3.06M▼ -10.7% vs 2024lowest in 7 years
2019 → 2025
Net result
€98k▼ 76.3%
2024 · €413k
2019: €173k
2020: €222k▲ +28.1% vs 2019
2021: €114k▼ -48.8% vs 2020
2022: €253k▲ +122% vs 2021
2023: €180k▼ -28.6% vs 2022
2024: €413k▲ +129% vs 2023highest in 7 years
2025: €98k▼ -76.3% vs 2024lowest in 7 years
2019 → 2025
Working capital
€657k▲ 5.0%
2024 · €626k
2019: €2.63M
2020: €2.81M▲ +6.9% vs 2019
2021: €2.75M▼ -1.9% vs 2020
2022: €3.04M▲ +10.3% vs 2021
2023: €3.08M▲ +1.4% vs 2022highest in 7 years
2024: €626k▼ -79.7% vs 2023lowest in 7 years
2025: €657k▲ +5.0% vs 2024
2019 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€2.95M-€3.18M▲ 8.0%€3.34M▲ 4.9%€477k▼ 85.7%€559k▲ 17.2%
2021: €2.95M
2022: €3.18M▲ +8.0% vs 2021
2023: €3.34M▲ +4.9% vs 2022highest in 5 years
2024: €477k▼ -85.7% vs 2023lowest in 5 years
2025: €559k▲ +17.2% vs 2024
Operating result€214k-€322k▲ 50.2%€211k▼ 34.4%€249k▲ 18.1%€133k▼ 46.8%
2021: €214k
2022: €322k▲ +50.2% vs 2021highest in 5 years
2023: €211k▼ -34.4% vs 2022
2024: €249k▲ +18.1% vs 2023
2025: €133k▼ -46.8% vs 2024lowest in 5 years
Net result€114k-€253k▲ 122%€180k▼ 28.6%€413k▲ 129%€98k▼ 76.3%
2021: €114k
2022: €253k▲ +122% vs 2021
2023: €180k▼ -28.6% vs 2022
2024: €413k▲ +129% vs 2023highest in 5 years
2025: €98k▼ -76.3% vs 2024lowest in 5 years
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 47% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.06M
Fixed assets
€1.74M ▼ 4.0%
Current assets
€1.33M ▼ 18.1%
Equity and liabilities €3.06M
Equity
€559k ▲ 17.2%
Debt
€2.50M ▼ 15.2%
Debt's share of the balance-sheet total falls from 86.1% to 81.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€237k▼
2024 · €352k
Cash flow
€202k▼
2024 · €516k
Current ratio
1.98▲
2024 · 1.63
Quick ratio
1.21▲
2024 · 1.10
Debt to equity
4.48▼
2024 · 6.19
ROE
17.5%▼
2024 · 86.6%
ROA
3.2%▼
2024 · 12.0%
Interest coverage
4.46▲
2024 · 2.26
Debt ≤ 1 year
€671k▼
2024 · €996k
Debt > 1 year
€1.83M▼
2024 · €1.95M
Income taxes
€36k▼
2024 · €53k
Staff costs
€525k▼
2024 · €529k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 57 lines
Balance sheet
Code20242025
Assets
Total assets20/58€3.43M€3.06M▼
Fixed assets21/28€1.81M€1.74M▼
Tangible fixed assets22/27€1.81M€1.74M▼
Land and buildings22€1.66M€1.60M▼
Plant, machinery and equipment23€147k€137k▼
Current assets29/58€1.62M€1.33M▼
Stocks and contracts in progress3€524k€519k▼
Stocks30/36€524k€519k▼
Amounts receivable within one year40/41€248k€275k▲
Trade receivables40€205k€216k▲
Other amounts receivable41€43k€59k▲
Current investments50/53€403k€373k▼
Cash at bank and in hand54/58€446k€160k▼
Deferred charges and accrued income490/1€759€2k▲
Equity and liabilities
Total equity and liabilities10/49€3.43M€3.06M▼
Equity10/15€477k€559k▲
Contributions10/11€19k€19k=
Reserves13€71k€71k=
Distributable reserves133€71k€71k=
Profit (loss) carried forward14€388k€470k▲
Amounts payable17/49€2.95M€2.50M▼
Amounts payable after more than one year17€1.95M€1.83M▼
Financial debts170/4€1.95M€1.83M▼
Amounts payable within one year42/48€996k€671k▼
Current portion of amounts payable after more than one year42€266k€194k▼
Financial debts43€32k€32k▲
Credit institutions430/8€32k€32k▲
Trade debts44€367k€368k▲
Suppliers440/4€367k€368k▲
Taxes, remuneration and social security45€56k€60k▲
Taxes450/3€1k€13▼
Remuneration and social security454/9€55k€60k▲
Other amounts payable47/48€275k€16k▼
Accrued charges and deferred income492/3€4k€4k▼
Income statement
Code20242025
Non-recurring operating income76A-€2k
Remuneration, social security and pensions62€529k€525k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€103k€105k▲
Other operating charges640/8€6k€3k▼
Non-recurring operating charges66A€9k-
Gross operating margin9900€897k€765k▼
Operating profit (loss)9901€249k€133k▼
Financial income75/76B€372k€55k▼
Recurring financial income75€370k€52k▼
Non-recurring financial income76B€2k€2k▲
Financial charges65/66B€156k€53k▼
Recurring financial charges65€156k€53k▼
Profit (loss) for the period before taxes9903€466k€134k▼
Income taxes67/77€53k€36k▼
Profit (loss) for the period9904€413k€98k▼
Profit (loss) for the period to be appropriated9905€413k€98k▼
Appropriation of the result
Profit (loss) to be appropriated9906€3.45M€485k▼
Profit (loss) brought forward from the previous period14P€3.03M€388k▼
Transfer from equity791/2€216k-
Profit to be distributed694/7€3.28M€16k▼
Return on contributions (dividend)694€3.25M-
Employees696€25k€16k▼
Social balance
Average headcount (FTE)90879.28.7▼
The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €2k | - |
| Remuneration, social security and pensions62 | - | €387k | €489k | €529k | €525k | ▼ 0.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €70k | €83k | €81k | €103k | €105k | ▲ 1.6% |
| Other operating charges640/8 | - | €4k | €5k | €6k | €3k | ▼ 42.1% |
| Non-recurring operating charges66A | - | - | - | €9k | - | - |
| Gross operating margin9900 | €645k | €797k | €785k | €897k | €765k | ▼ 14.7% |
| Operating profit (loss)9901 | €214k | €322k | €211k | €249k | €133k | ▼ 46.8% |
| Financial income75/76B | - | €41k | €20k | €372k | €55k | ▼ 85.3% |
| Recurring financial income75 | €40k | €39k | €17k | €370k | €52k | ▼ 85.8% |
| Non-recurring financial income76B | - | €2k | €3k | €2k | €2k | ▲ 5.0% |
| Financial charges65/66B | - | €28k | €45k | €156k | €53k | ▼ 65.9% |
| Recurring financial charges65 | €92k | €28k | €45k | €156k | €53k | ▼ 65.9% |
| Profit (loss) for the period before taxes9903 | €164k | €335k | €186k | €466k | €134k | ▼ 71.2% |
| Income taxes67/77 | €51k | €82k | €6k | €53k | €36k | ▼ 31.4% |
| Profit (loss) for the period9904 | €114k | €253k | €180k | €413k | €98k | ▼ 76.3% |
| Profit (loss) for the period to be appropriated9905 | €114k | €253k | €180k | €413k | €98k | ▼ 76.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €4.38M | €5.04M | €6.24M | €3.43M | €3.06M | ▼ 10.7% |
| Fixed assets21/28 | €890k | €1.16M | €2.34M | €1.81M | €1.74M | ▼ 4.0% |
| Tangible fixed assets22/27 | €890k | €1.16M | €2.34M | €1.81M | €1.74M | ▼ 4.0% |
| Land and buildings22 | - | €1.08M | €2.15M | €1.66M | €1.60M | ▼ 3.8% |
| Plant, machinery and equipment23 | - | €78k | €186k | €147k | €137k | ▼ 6.4% |
| Current assets29/58 | €3.49M | €3.87M | €3.90M | €1.62M | €1.33M | ▼ 18.1% |
| Stocks and contracts in progress3 | €440k | €419k | €493k | €524k | €519k | ▼ 1.0% |
| Stocks30/36 | - | €419k | €493k | €524k | €519k | ▼ 1.0% |
| Amounts receivable within one year40/41 | €388k | €407k | €493k | €248k | €275k | ▲ 10.7% |
| Trade receivables40 | - | €185k | €192k | €205k | €216k | ▲ 5.1% |
| Other amounts receivable41 | - | €223k | €301k | €43k | €59k | ▲ 37.8% |
| Current investments50/53 | €2.31M | €2.74M | €2.74M | €403k | €373k | ▼ 7.5% |
| Cash at bank and in hand54/58 | €349k | €305k | €172k | €446k | €160k | ▼ 64.2% |
| Deferred charges and accrued income490/1 | - | €6k | €319 | €759 | €2k | ▲ 161% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €4.38M | €5.04M | €6.24M | €3.43M | €3.06M | ▼ 10.7% |
| Equity10/15 | €2.95M | €3.18M | €3.34M | €477k | €559k | ▲ 17.2% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €287k | €287k | €287k | €71k | €71k | = |
| Non-distributable reserves130/1 | - | €2k | - | - | - | - |
| Reserves not available under the articles1311 | - | €2k | - | - | - | - |
| Distributable reserves133 | - | €285k | €287k | €71k | €71k | = |
| Profit (loss) carried forward14 | €2.64M | €2.88M | €3.03M | €388k | €470k | ▲ 21.1% |
| Amounts payable17/49 | €1.43M | €1.85M | €2.90M | €2.95M | €2.50M | ▼ 15.2% |
| Amounts payable after more than one year17 | €694k | €1.01M | €2.07M | €1.95M | €1.83M | ▼ 6.3% |
| Financial debts170/4 | - | €1.01M | €2.07M | €1.95M | €1.83M | ▼ 6.3% |
| Amounts payable within one year42/48 | €733k | €835k | €823k | €996k | €671k | ▼ 32.6% |
| Current portion of amounts payable after more than one year42 | - | €57k | €251k | €266k | €194k | ▼ 26.9% |
| Financial debts43 | - | €32k | €32k | €32k | €32k | ▲ 0.6% |
| Credit institutions430/8 | - | €32k | €32k | €32k | €32k | ▲ 0.6% |
| Trade debts44 | €604k | €684k | €461k | €367k | €368k | ▲ 0.3% |
| Suppliers440/4 | - | €684k | €461k | €367k | €368k | ▲ 0.3% |
| Taxes, remuneration and social security45 | - | €43k | €56k | €56k | €60k | ▲ 8.0% |
| Taxes450/3 | - | - | - | €1k | €13 | ▼ 98.9% |
| Remuneration and social security454/9 | - | €43k | €56k | €55k | €60k | ▲ 10.3% |
| Other amounts payable47/48 | - | €18k | €23k | €275k | €16k | ▼ 94.2% |
| Accrued charges and deferred income492/3 | - | €3k | €4k | €4k | €4k | ▼ 14.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €114k | €253k | €180k | €413k | €98k | ▼ 76.3% |
| + Depreciation and write-downs630 | €70k | €83k | €81k | €103k | €105k | ▲ 1.6% |
| Operating cash flow (approximation) | €184k | €336k | €261k | €516k | €202k | ▼ 60.8% |
| Investment in fixed assets (approximation) | - | €-356k | €-1.26M | €429k | €-32k | ▼ 108% |
| Change in cash | - | €-44k | €-133k | €274k | €-286k | ▼ 204% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
31-03
Financial
Weakest financial yearnet €98k ▼76.3%
Net result drops to €98k, the lowest in the series.
31-03
Financial
Equity above €500kEq €559k ▲17.2%
7 profitable years in a row build equity to €559k.
2024
29-10
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
31-03
Financial
Highest result since 2019net €413k ▲129%
Net result €413k, the highest in the series.
2023
31-10
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
28-10
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
15-11
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 15 days late
2020
17-11
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 17 days late
2019
24-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
14-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
06-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kapellen · 1 establishment unit since 2000
Ground area
1,164 m²
Building footprint
317 m²
Volume, LiDAR
1,726 m³
Parcel 11362N0339/02W000, Flanders · tallest building 11.6 m, ±1 floor. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Antwerpsesteenweg 188, 2950 Kapellen
since 20002.097.435.354
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11362N0339/02W000 | Flanders | 1,164 m² | 1 · 317 m² | 11.6 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2024 · 2 entries · 1,155 EUR awarded · 1,155 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 600 EUR | 600 EUR |
| 2023 | 1 | 555 EUR | 555 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
Apotheek THYS
BE 0425.115.168
Houthalen-Helchteren · Eq €559,152
APOTHEEK DE LAET
BE 0405.063.684
Sint-Niklaas · Eq €559,191
THOMAS BROOS
BE 0822.320.765
Herent · Eq €559,727
APOTHEEK op OVERSCHELDE
BE 0879.052.107
Wetteren · Eq €557,983
PHARMA HESBAYE
BE 0773.878.173
Liège · Eq €557,416
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,313 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded26-10-1999
Fiscal year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.